Omeros (OMER) Assets Average (2011 - 2026)
Omeros' (OMER) quarterly Assets Average came in at $305.9 million in Q1 2026, up 19.44% year-on-year from $256.1 million in Q1 2025, and up 19.65% quarter-over-quarter from $255.7 million in Q4 2025.
Omeros (OMER) Assets Average (2011 - 2026) Analysis & Trends
Omeros has disclosed Assets Average across 16 years of filings, most recently posting $305.9 million for Q1 2026.
- Assets Average for Q1 2026 came in at $305.9 million, up 19.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $305.9 million (up 19.44% YoY), and the FY2025 annual result was $301.4 million, down 8.03% from the prior year.
- Assets Average came in at $305.9 million for Q1 2026 at Omeros, up from $255.7 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $575.6 million in Q1 2023 to a low of $193.1 million in Q3 2025.
- The 5-year median for Assets Average is $394.3 million (2022), against an average of $376.8 million.
- Across the five-year window, Assets Average jumped 198.78% in 2022 and sank 45.11% in 2025, its largest moves.
- Omeros' Assets Average stood at $524.3 million in 2022, then fell by 16.9% to $435.7 million in 2023, then slumped by 32.24% to $295.2 million in 2024, then slipped by 13.39% to $255.7 million in 2025, then grew by 19.65% to $305.9 million in 2026.
- The last three Assets Average figures came in at $305.9 million (Q1 2026), $255.7 million (Q4 2025), and $193.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | 305.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305.90 Mn |
| Dec 31, 2025 | 255.67 Mn |
| Sep 30, 2025 | 193.14 Mn |
| Jun 30, 2025 | 217.87 Mn |
| Mar 31, 2025 | 256.12 Mn |
| Dec 31, 2024 | 295.21 Mn |
| Sep 30, 2024 | 334.82 Mn |
| Jun 30, 2024 | 396.90 Mn |
| Mar 31, 2024 | 407.88 Mn |
| Dec 31, 2023 | 435.67 Mn |
| Sep 30, 2023 | 510.25 Mn |
| Jun 30, 2023 | 543.78 Mn |
| Mar 31, 2023 | 575.55 Mn |
| Dec 31, 2022 | 524.26 Mn |
| Sep 30, 2022 | 401.59 Mn |
| Jun 30, 2022 | 357.45 Mn |
| Mar 31, 2022 | 394.27 Mn |
| Dec 31, 2021 | 271.35 Mn |
| Sep 30, 2021 | 134.41 Mn |
| Jun 30, 2021 | 153.42 Mn |